Dr. Hoffmann is a full professor at Leipzig University. His research has a strong background in the design and optimization of peptide drug candidates and compound vaccines as well as proteomics and lipidomics. Technically, his focus is on peptide chemistry and protein/lipid analytics including sensitive immunoassays and mass spectrometry to study enzymatic and non-enzymatic modifications in the context of cellular aging, oxidative stress, and diabetes. He is the author of 200 peer-reviewed scientific publications and co-inventor on ten patent applications. He did his postdoctoral research at The Wistar Institute (Philadelphia, USA) with Dr. L. Otvos and is a cofounder of AMP-Therapeutics GmbH.